Leading the epigenomics revolution through groundbreaking research tools
Cambridge Epigenetix has raised €24M across 2 funding rounds from 5 investors, most recently a Series B round in Mar 2016. Based in Cambridge, UK; founded 2012; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2016-03-01 | Series B | €19M | GV (Google Ventures),New Science Ventures,Sequoia Capital,Syncona Partners | View deal → |
| 2014-10-01 | Series A | €4.4M | Cambridge Enterprise,New Science Ventures,Syncona Partners | View deal → |
